Economic evaluation of a randomized controlled trial comparing mifepristone and misoprostol with misoprostol alone in the treatment of early pregnancy loss

Economic evaluation of a randomized controlled trial comparing mifepristone and misoprostol with misoprostol alone in the treatment of early pregnancy loss

Show other versions (1)

<h4>Background</h4> In case of early pregnancy loss (EPL) women can either choose for expectant, medical or surgical management. One week of expectant management is known to lead to spontaneous abortion in approximately 50% of women. Medical treatment with misoprostol is known to be safe...

ver descrição completa

Detalhes bibliográficos
Main Authors: Charlotte C. Hamel, Marcus P. L. M. Snijders, Sjors F. P. J. Coppus, Frank P. H. A. Vandenbussche, Didi D. M. Braat, Eddy M. M. Adang
Formato: Artigo
Idioma:English
Publicado em: Public Library of Science (PLoS) 2022-01-01
Colecção:PLoS ONE
Acesso em linha:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827447/?tool=EBI

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827447/?tool=EBI

Registos relacionados